Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 3, 2014
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski, Joshua E Meyer, Michael Joiner, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2004
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer
Steven J Cohen, James Gallo, Nancy L Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
Peter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, et al.
Annals of Surgical Oncology
|
August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancer
Yun Shin Chun, Barton N Milestone, James C Watson, et al.
Cancer Biology & Therapy
|
November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer
Kalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
Journal of Pancreatic Cancer
|
June 7, 2021
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis
Amy E McGhee-Jez, Inna Chervoneva, Misung Yi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer
Efrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
American Journal of Clinical Oncology
|
March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection
Patrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
January 24, 2012
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel
Bertrand Janne d'Othée, Constantinos T Sofocleous, Nader Hanna, et al.
JCO Precision Oncology
|
December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy
Ida Micaily, Edik M Blais, Randi Carhart, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 3, 2014
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski, Joshua E Meyer, Michael Joiner, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2004
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer
Steven J Cohen, James Gallo, Nancy L Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
Peter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, et al.
Annals of Surgical Oncology
|
August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancer
Yun Shin Chun, Barton N Milestone, James C Watson, et al.
Cancer Biology & Therapy
|
November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer
Kalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
Journal of Pancreatic Cancer
|
June 7, 2021
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis
Amy E McGhee-Jez, Inna Chervoneva, Misung Yi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer
Efrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
American Journal of Clinical Oncology
|
March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection
Patrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
January 24, 2012
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel
Bertrand Janne d'Othée, Constantinos T Sofocleous, Nader Hanna, et al.
JCO Precision Oncology
|
December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy
Ida Micaily, Edik M Blais, Randi Carhart, et al.
Page
of 11